EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC)

Dellas, K. and Roedel, F. and Arnold, D. and Kappler, M. and Hipp, M. and Bataille, F. and Vordermark, D. and Roedel, C. and Hartmann, A. (2010) EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC). JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 15 Apr 2020 08:39
Last Modified: 15 Apr 2020 08:39
URI: https://pred.uni-regensburg.de/id/eprint/24714

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.